After the Pfizer vaccine was approved by the U.S. Food and Drug Administration (FDA), a group of over 30 prominent academic scientists, professors, and physicians from some of the nation’s most prestigious institutions sought publicly available access to the Pfizer Biologics License Application (BLA). Working with the law firm of Siri Glimstad, the Public Health and Medical Professionals for Transparency (PHMPT), submitted a Freedom of Information Act (FOIA) Request to the FDA to access all data within Pfizer’s COVID-19 vaccine biological product file. With unacceptable responses, the transparency-seeking organization sued the FDA in the U.S. District Court, Northern District of Texas to compel the FDA to disclose the material documentation associated with Pfizer’s FDA submission in an expedited manner. Rather than share any information, the FDA requested from the federal judge that it be given until 2076 to share the Pfizer vaccine information with the public.
While the FOIA process can be slow and tedious, nothing could have prepared this group of prominent scientists/doctors for the scenario where the FDA wouldn’t have to share important data for 55 years.
In the “Second ...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).